X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Natco Pharma with Piramal Healthcare - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NATCO PHARMA vs PIRAMAL ENTERPRISES - Comparison Results

PIRAMAL ENTERPRISES 
   Change

Piramal Enterprises has a presence in custom manufacturing, critical care OTC and financial services. To give a boost to its custom manufacturing operations, the company had acquired Avecia Pharmaceuticals, UK in 2005 and Pfizer's Morpeth facility in... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    NATCO PHARMA PIRAMAL ENTERPRISES NATCO PHARMA/
PIRAMAL ENTERPRISES
 
P/E (TTM) x 32.6 36.5 89.2% View Chart
P/BV x 16.6 3.6 455.6% View Chart
Dividend Yield % 0.7 0.7 103.3%  

Financials

 NATCO PHARMA   PIRAMAL ENTERPRISES
EQUITY SHARE DATA
    NATCO PHARMA
Mar-14
PIRAMAL ENTERPRISES
Mar-16
NATCO PHARMA/
PIRAMAL ENTERPRISES
5-Yr Chart
Click to enlarge
High Rs8771,065 82.3%   
Low Rs424805 52.6%   
Sales per share (Unadj.) Rs223.4383.0 58.3%  
Earnings per share (Unadj.) Rs31.155.1 56.4%  
Cash flow per share (Unadj.) Rs40.374.1 54.4%  
Dividends per share (Unadj.) Rs5.0017.50 28.6%  
Dividend yield (eoy) %0.81.9 41.1%  
Book value per share (Unadj.) Rs219.5719.9 30.5%  
Shares outstanding (eoy) m33.07172.56 19.2%   
Bonus/Rights/Conversions PA--  
Price / Sales ratio x2.92.4 119.2%   
Avg P/E ratio x20.917.0 123.3%  
P/CF ratio (eoy) x16.112.6 127.9%  
Price / Book Value ratio x3.01.3 228.1%  
Dividend payout %16.131.8 50.7%   
Avg Mkt Cap Rs m21,504161,344 13.3%   
No. of employees `000NA3.8 0.0%   
Total wages/salary Rs m1,12816,898 6.7%   
Avg. sales/employee Rs ThNM17,472.6-  
Avg. wages/employee Rs ThNM4,466.9-  
Avg. net profit/employee Rs ThNM2,512.8-  
INCOME DATA
Net Sales Rs m7,38966,099 11.2%  
Other income Rs m1672,425 6.9%   
Total revenues Rs m7,55668,524 11.0%   
Gross profit Rs m1,79318,723 9.6%  
Depreciation Rs m3043,274 9.3%   
Interest Rs m3669,388 3.9%   
Profit before tax Rs m1,2908,485 15.2%   
Minority Interest Rs m463 1,403.0%   
Prior Period Items Rs m01,593 0.0%   
Extraordinary Inc (Exp) Rs m0457 0.0%   
Tax Rs m3091,032 29.9%   
Profit after tax Rs m1,0279,506 10.8%  
Gross profit margin %24.328.3 85.7%  
Effective tax rate %23.912.2 196.8%   
Net profit margin %13.914.4 96.7%  
BALANCE SHEET DATA
Current assets Rs m3,68147,488 7.8%   
Current liabilities Rs m3,123104,362 3.0%   
Net working cap to sales %7.6-86.0 -8.8%  
Current ratio x1.20.5 259.1%  
Inventory Days Days8941 220.3%  
Debtors Days Days5951 114.7%  
Net fixed assets Rs m7,68526,532 29.0%   
Share capital Rs m331345 95.8%   
"Free" reserves Rs m6,670114,024 5.8%   
Net worth Rs m7,259124,221 5.8%   
Long term debt Rs m95575,812 1.3%   
Total assets Rs m11,957308,356 3.9%  
Interest coverage x4.51.9 237.5%   
Debt to equity ratio x0.10.6 21.6%  
Sales to assets ratio x0.60.2 288.3%   
Return on assets %11.76.1 190.2%  
Return on equity %14.27.7 185.0%  
Return on capital %20.710.0 208.1%  
Exports to sales %39.417.2 229.0%   
Imports to sales %5.76.6 86.3%   
Exports (fob) Rs m2,90811,362 25.6%   
Imports (cif) Rs m4214,364 9.7%   
Fx inflow Rs m3,44514,435 23.9%   
Fx outflow Rs m7035,183 13.6%   
Net fx Rs m2,7439,253 29.6%   
CASH FLOW
From Operations Rs m1,440-67,773 -2.1%  
From Investments Rs m-1,089-8,768 12.4%  
From Financial Activity Rs m-35376,199 -0.5%  
Net Cashflow Rs m-1-342 0.4%  

Share Holding

Indian Promoters % 52.0 52.9 98.4%  
Foreign collaborators % 1.5 0.0 -  
Indian inst/Mut Fund % 7.8 4.0 196.0%  
FIIs % 16.6 26.6 62.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 26.0 16.5 157.6%  
Shareholders   25,395 93,274 27.2%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare NATCO PHARMA With:   PFIZER  GSK PHARMA  PLETHICO PHARMA  DR. REDDYS LAB  ABBOTT INDIA  

Compare NATCO PHARMA With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Finishes on a Strong Note; Bank & Realty Stocks Rally(Closing)

Indian share markets surged further in the afternoon session and finished in the green for the second straight session on heavy buying in realty stocks, metal stocks and bank stocks.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

This Small Cap Can Drive Chinese Players Out of India (and Make a Fortune in the Process)(The 5 Minute Wrapup)

Aug 17, 2017

A small-cap Indian company with high-return potential and blue-chip-like stability is set to supplant the Chinese players in this niche segment.

The Most Important Innovation in Finance Since Gold Coins(Vivek Kaul's Diary)

Aug 10, 2017

Bill connects the dots...between money and growth, real money and real resources, gold and cryptocurrencies...and between gold, cryptocurrencies, and time.

It's the Best Time to Buy IT Stocks(Daily Profit Hunter)

Aug 16, 2017

The IT Sector could be in an uptrend till February 2019. Are you prepared to ride the trend?

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

NATCO PHARMA SHARE PRICE


Aug 23, 2017 03:36 PM

TRACK NATCO PHARMA

  • Track your investment in NATCO PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

NATCO PHARMA 5-YR ANALYSIS

COMPARE NATCO PHARMA WITH

MARKET STATS